Вход на сайт
Просмотр новости

Найдите то, что Вас интересует

Enrollment cuts and primary-outcome changes, not completion-date delays, predict the termination of industry phase 2–3 drug trials: a landmark analysis of ClinicalTrials.gov version histories
Дата публикации: 22-10-2026 05:49:36

An article created on 2026-10-22 05:49:36

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1A dataset linking 45,988 finished phase 2–3 drug trials on ClinicalTrials.gov (2010–2026) to subsequent FDA approval of the drugs tested016.6422-10-2026
2Selective uptake of medicines outside China's National Reimbursement Drug List by commercial specialty-drug rosters: a multi-product audit of the 2020–2025 negotiation cohorts019.6321-10-2026
3Clinical Tasks Explain AI Readiness Across Medical Specialties017.1422-10-2026
4Federated Model Optimization for Real-Time Big Data Analytics in Smart Drug Delivery Edge Devices02019-08-2026
5Delayed verification and communication of critical laboratory results in a Nigerian tertiary hospital: a case based quality improvement report013.0622-10-2026
6Implementation Variability Makes Sepsis-3 an Inconsistent Measuring Model for Early AI Prediction on Clinical Data012.4920-08-2026
7Time to Maximal Response of Trastuzumab Deruxtecan in Patients with HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study (TRACE)0515-07-2026
8Sodium-Glucose Cotransporter-2 Inhibitors and Cutaneous Adverse Reactions: A Systematic Review of Clinical Phenotypes, Time-to- Onset Profiles, and Management Strategies (2020–2026)0715-07-2026
9Inflationary bibliometric values revisited: Indicator validity under falling production costs016.2520-08-2026
10Patient Preferences for Biologic Therapies in Chronic Disease: A Systematic Review of Discrete Choice Experiments014.7610-08-2026

Классификация: Мнения. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 19.01. Источник: www.researchsquare.com.